Universal gene‑edited CAR‑T therapies turn donor T cells into off‑the‑shelf cancer treatments, cutting delays and costs while ...
The FDA granted orphan drug designation to CTD402 for relapsed or refractory T-cell acute lymphoblastic leukemia and ...
Although rheumatologists consider chimeric antigen receptor T-cell therapy “potentially transformative,” nearly 70% remain ...
A new cancer therapy wakes up immune cells inside tumors and turns them against cancer.
The cell and gene therapy sector has never lacked attention, but all too often, the narrative swings from one extreme to ...
Early results from the ongoing QUILT-106 clinical trial (NCT06334991) show that the treatment combination of CD19 chimeric antigen receptor natural killer (CAR-NK) cells with rituximab (Rituxan) can ...
Under the agreement, participating states will receive “discounts and rebates” from the drugmakers if the treatments don’t ...
Multiply Labs' goal is to enable scalable, high-throughput manufacturing while maintaining rigorous quality and regulatory standards.
According to Mayo Clinic, stem cells are a special type of cell that have two important properties that make more cells like ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results